Endocrine

, Volume 38, Issue 2, pp 181–187 | Cite as

Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus

  • Yifei Zhang
  • Xi Lu
  • Jie Hong
  • Menglei Chao
  • Weiqiong Gu
  • Weiqing Wang
  • Guang Ning
Original Article

Abstract

It has long been proposed that elevation of liver enzymes including alanine aminotransferase (ALT), aspartate aminotransferase (AST) and γ-glutamyltransferase (GGT) may be associated with insulin resistance (IR). In the present study, we aimed to investigate the association of the above mentioned liver enzymes with IR by using hyperinsulinemic euglycemic clamp, as well as their relationship with individual component of metabolic syndrome (MetS) in 95 newly diagnosed type 2 diabetes (T2DM) Chinese patients. All the diagnosed patients did not use drugs for treatment of diabetes or dyslipidemia previously and were divided into IR and non-IR groups. The results showed that IR group had significantly higher ALT, AST, and GGT (P < 0.01, P < 0.01, and P < 0.05, respectively) compared with non-IR group. According to the individual MetS component, ALT and AST were significantly increased in patients with high blood pressure compared with those without (both P < 0.001); ALT and GGT were increased in patients with high triglyceride (P < 0.05 and P < 0.01); AST was increased in patients with central obesity (P < 0.05). In correlation analysis, a significant association was found between the three liver enzymes and clamp insulin sensitivity index (all P < 0.001). In the linear regression analysis, ALT was the determinant of clamp ISI, independent of age, sex, BMI, and fasting and OGTT 2 h plasma glucose (P < 0.0001). In conclusion, liver enzymes, especially ALT, were significantly associated with IR according to direct clamp assessment, which were independent of the traditional risk factors in diabetic patients; and individual liver enzymes may have different relationship with individual component of MetS.

Keywords

Liver enzymes Hyperinsulinemic euglycemic clamp Insulin resistance Metabolic syndrome 

Notes

Acknowledgments

This study is supported by the grant from 973 Project (No. 2006 CB 503904), National Natural Science Foundation of China (No. 30725037 and No. 30700383), and 863 project (NO: 2006AA02A409).

Conflict of interest statement

None.

References

  1. 1.
    S.D. Lidofsky, Curr. Diab. Rep. 8, 25–30 (2008)CrossRefPubMedGoogle Scholar
  2. 2.
    A.J. Hanley, L.E. Wagenknecht, A. Festa, R.B. D’Agostino Jr., S.M. Haffner, Diabetes Care 30, 1819–1827 (2007)CrossRefPubMedGoogle Scholar
  3. 3.
    C. Weyer, P.A. Tataranni, C. Bogardus, R.E. Pratley, Diabetes Care 24, 89–94 (2001)CrossRefPubMedGoogle Scholar
  4. 4.
    C. Weyer, C. Bogardus, D.M. Mott, R.E. Pratley, J. Clin. Invest. 104, 787–794 (1999)CrossRefPubMedGoogle Scholar
  5. 5.
    A.J. Hanley, K. Williams, A. Festa, L.E. Wagenknecht, R.B. D’Agostino Jr., S.M. Haffner, Diabetes 54, 3140–3147 (2005)CrossRefPubMedGoogle Scholar
  6. 6.
    S.G. Wannamethee, L. Lennon, P.H. Whincup, Diabetes Care 28, 2913–2918 (2005)CrossRefPubMedGoogle Scholar
  7. 7.
    M. Nannipieri, C. Gonzales, S. Baldi, R. Posadas, K. Williams, S.M. Haffner, M.P. Stern, E. Ferrannini, Diabetes Care 28, 1757–1762 (2005)CrossRefPubMedGoogle Scholar
  8. 8.
    P. André, B. Balkau, S. Vol, M.A. Charles, E. Eschwège, DESIR Study Group, Diabetes Care 30, 2355–2361 (2007)CrossRefPubMedGoogle Scholar
  9. 9.
    R.K. Schindhelm, J.M. Dekker, G. Nijpels, C.D. Stehouwer, L.M. Bouter, R.J. Heine, M. Diamant, Diabet. Med. 24, 430–435 (2007)CrossRefPubMedGoogle Scholar
  10. 10.
    A.J. Hanley, K. Williams, A. Festa, L.E. Wagenknecht, R.B. D’Agostino Jr., J. Kempf, B. Zinman, S.M. Haffner, Diabetes 53, 2623–2632 (2004)CrossRefPubMedGoogle Scholar
  11. 11.
    Y.S. Lee, Y.K. Cho, J.C. Pae, S.Y. Oh, M.S. Kang, J.H. Park, H.J. Kim, D.I. Park, C.I. Sohn, W.K. Jeon et al., Korean J. Hepatol. 12, 221–229 (2006)PubMedGoogle Scholar
  12. 12.
    Y.J. Lee, D.G. Kang, J.S. Kim, H.S. Lee, Vascul Pharmacol 48, 38–46 (2008)CrossRefPubMedGoogle Scholar
  13. 13.
    S.K. Kogawa, T. Hayashi, Y. Nakamura, N. Harita, T. Yoneda, G. Endo, H. Kambe, Diabetes Care 31, 1230–1236 (2008)CrossRefGoogle Scholar
  14. 14.
    E.S. Ford, M.B. Schulze, M.M. Bergmann, C. Thamer, H.G. Joost, H. Boeing, Diabetes Care 31, 1138–1143 (2008)CrossRefPubMedGoogle Scholar
  15. 15.
    B. Vozarova, N. Stefan, R.S. Lindsay, A. Saremi, R.E. Pratley, C. Bogardus, P.A. Tataranni, Diabetes 51, 1889–1895 (2002)CrossRefPubMedGoogle Scholar
  16. 16.
    Y. Miyake, H. Eguchi, K. Shinchi, T. Oda, S. Sasazuki, S. Kono, J. Hepatol. 38, 18–23 (2003)CrossRefPubMedGoogle Scholar
  17. 17.
    N. Nakanishi, K. Suzuki, K. Tatara, Diabetes Care 27, 1427–1432 (2004)CrossRefPubMedGoogle Scholar
  18. 18.
    C. Postic, J. Girard, J. Clin. Invest. 118, 829–838 (2008)CrossRefPubMedGoogle Scholar
  19. 19.
    I.R. Hsu, S.P. Kim, M. Kabir, R.N. Bergman, Am. J. Clin. Nutr. 86, s867–s871 (2007)Google Scholar
  20. 20.
    L.A. Adams, Endocr. Res. 32, 59–69 (2007)CrossRefPubMedGoogle Scholar
  21. 21.
    S. Bellentani, G.R. Dalle, A. Suppini, G. Marchesini, Hepatology 47, 746–754 (2008)CrossRefPubMedGoogle Scholar
  22. 22.
    E. Ortega, J. Koska, A.D. Salbe, P.A. Tataranni, J.C. Bunt, J. Clin. Endocrinol. Metab. 91, 1419–1422 (2006)CrossRefPubMedGoogle Scholar
  23. 23.
    M.M. Gabir, R.L. Hanson, D. Dabelea, G. Imperatore, J. Roumain, P.H. Bennett, W.C. Knowler, Diabetes Care 23, 1108–1112 (2000)CrossRefPubMedGoogle Scholar
  24. 24.
    Y. Li, J.G. Wang, P.J. Gao, G.L. Wang, Y.S. Qian, D.L. Zhu, J.A. Staessen, Am. J. Hypertens. 19, 448–453 (2006)CrossRefPubMedGoogle Scholar
  25. 25.
    Y. Zhang, X. Li, D. Zou, W. Liu, J. Yang, N. Zhu, L. Huo, M. Wang, J. Hong, P. Wu, G. Ren, G. Ning, J. Clin. Endocrinol. Metab. 93, 2559–2565 (2008)CrossRefPubMedGoogle Scholar
  26. 26.
    S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.J. Gordon, R.M. Krauss, P.J. Savage, S.C. Smith Jr., J.A. Spertus, F. Costa, Circulation 112, 2735–2752 (2005)CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Yifei Zhang
    • 1
  • Xi Lu
    • 1
  • Jie Hong
    • 1
  • Menglei Chao
    • 1
  • Weiqiong Gu
    • 1
  • Weiqing Wang
    • 1
  • Guang Ning
    • 1
    • 2
  1. 1.Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrinology and Metabolism, Endocrine and Metabolic E-Institutes of Shanghai Universities (EISU) and Key Laboratory for Endocrinology and Metabolism of Chinese Health Ministry, Rui-jin HospitalShanghai Jiao-Tong University, School of MedicineShanghaiChina
  2. 2.Laboratory of Endocrinology and Metabolism, Institute of Health Sciences, Shanghai Institutes for Biological SciencesChinese Academy of Sciences/Shanghai Jiao-Tong University School of MedicineShanghaiChina

Personalised recommendations